CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

Historical Holders from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CLOV on Nasdaq
Shares outstanding
416,598,522
Price per share
$2.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
135,304,614
Total reported value
$413,984,387
% of total 13F portfolios
0%
Share change
-10,988,558
Value change
-$32,285,814
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
198
Price from insider filings
$2.59
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.2% $101,366,396 29,813,646 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.8% $82,436,516 24,246,034 The Vanguard Group 30 Jun 2025
As of 30 Sep 2025, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 198 institutional shareholders filing 13F forms. They hold 135,304,614 shares. of 416,598,522 outstanding shares (32%) .

Top 25 institutional shareholders own 28% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.3% 30,394,942 -0.01% 0% $93,008,521
VANGUARD GROUP INC 5.5% 23,060,008 -4.9% 0% $70,563,625
GEODE CAPITAL MANAGEMENT, LLC 2.3% 9,720,407 -1.2% 0% $29,748,609
STATE STREET CORP 2.1% 8,951,676 +19% 0% $27,392,129
RENAISSANCE TECHNOLOGIES LLC 1.9% 7,712,700 -27% 0.03% $23,600,862
PNC Financial Services Group, Inc. 1.1% 4,463,811 0% 0.01% $13,659,262
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 4,271,515 +9.7% 0% $13,070,836
NORTHERN TRUST CORP 0.81% 3,373,192 -0.08% 0% $10,321,968
Divisadero Street Capital Management, LP 0.66% 2,768,088 0.39% $8,470,349
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.65% 2,701,896 -9.7% 0.01% $8,267,802
UBS Group AG 0.55% 2,282,113 +155% 0% $6,983,266
DIMENSIONAL FUND ADVISORS LP 0.51% 2,140,282 +199% 0% $6,551,257
MORGAN STANLEY 0.48% 2,013,401 -41% 0% $6,161,009
JANE STREET GROUP, LLC 0.47% 1,966,588 +315% 0.01% $6,017,759
CITADEL ADVISORS LLC 0.36% 1,487,650 -58% 0% $4,552,209
Soviero Asset Management, LP 0.34% 1,400,000 +56% 2.6% $4,284,000
GMT CAPITAL CORP 0.31% 1,305,200 0% 0.18% $3,993,912
GROUP ONE TRADING LLC 0.3% 1,237,171 +156% 0.11% $3,785,743
Bank of New York Mellon Corp 0.29% 1,193,626 +1.7% 0% $3,652,495
Invesco Ltd. 0.23% 957,957 -14% 0% $2,931,349
Nuveen, LLC 0.21% 883,536 -2.5% 0% $2,703,620
GOLDMAN SACHS GROUP INC 0.21% 866,410 -63% 0% $2,651,214
IMC-Chicago, LLC 0.21% 859,913 +77% 0.05% $2,631,334
JUPITER ASSET MANAGEMENT LTD 0.2% 850,884 -9.4% 0.02% $2,603,705
Atom Investors LP 0.2% 826,591 0.19% $2,529,368

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 172,672 $432,189 +$68,120 235.22% 4
2025 Q3 135,304,614 $413,984,387 -$32,285,814 306% 198
2025 Q2 146,128,655 $407,670,376 +$107,801,206 279% 197
2025 Q1 105,851,444 $380,012,727 +$48,891,890 359% 197
2024 Q4 92,755,820 $292,205,234 +$33,009,582 315% 173
2024 Q3 82,031,143 $231,318,548 +$27,511,703 282% 155
2024 Q2 73,207,343 $90,043,274 +$3,973,644 123% 121
2024 Q1 7,051,508 $5,599,626 -$1,059,295 79.4% 22
2023 Q4 274,090 $260,962 +$250,963 95.21% 3
2023 Q3 93,619,698 $101,106,888 -$3,079,042 108% 137
2023 Q2 96,770,526 $86,789,781 -$23,016,669 89.71% 139
2023 Q1 122,809,016 $103,788,160 -$1,405,031 84.51% 149
2022 Q4 125,674,620 $116,801,265 +$32,472 92.95% 164
2022 Q3 95,408,672 $162,192,913 -$3,255,763 170% 142
2022 Q2 122,194,291 $260,979,348 +$44,647,724 214% 153
2022 Q1 99,318,627 $352,608,942 -$114,700,465 355% 145
2021 Q4 129,960,531 $483,575,979 +$82,159,731 372% 141
2021 Q3 105,695,187 $781,321,828 -$326,733,403 738.99% 136
2021 Q2 141,939,893 $1,889,902,068 -$200,595,026 1,331.91% 136
2021 Q1 159,943,543 $1,205,602,044 +$1,204,190,639 756% 119
2020 Q4 74,982 $1,257,000 +$837,000 1,675.45% 10
2020 Q3 375% 0
2020 Q2 375% 0
2020 Q1 15,000 $113,000 $0 753.33% 1
2019 Q4 375% 0
2019 Q3 375% 0
2019 Q2 375% 0
2019 Q1 375% 0